Citigroup
BBP icon

Citigroup’s Virtus Biotech ETF BBP Stock Holding History

Citigroup’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83 Buy
+1
New +$82 ﹤0.01% 5617
2016
Q1 		– Sell
-41
Closed -$1K – 7450
2015
Q4 		$1K Buy
41
+35
+583% +$1.06K ﹤0.01% 7356
2015
Q3 		$0 Buy
+6
New +$202 ﹤0.01% 7371

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MSL
MILLINGTON SECURITIES, LLC Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return

Citigroup's BBP Position: Q1 2026 in Review

Citigroup opened a new position in Virtus Biotech ETF (BBP) in Q1 2026: 1 share worth $83. The stake represents ﹤0.01% of the portfolio and ranks #5617 among its holdings. This is a return to the name: Citigroup previously reported a position in BBP as recently as Q4 2015.

Citigroup first reported a position in BBP in Q3 2015 and has held it in 3 quarters since. The position peaked at $1K in Q4 2015. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • Citigroup held 1 share of Virtus Biotech ETF worth $83 as of Q1 2026.
  • Virtus Biotech ETF was a new Citigroup position in Q1 2026.
  • Virtus Biotech ETF made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5617 holding.
  • Citigroup first reported a position in Virtus Biotech ETF in Q3 2015 and has held it in 3 quarters since.
  • Citigroup's Virtus Biotech ETF position peaked at $1K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.